A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 39, Issue 3, 2007, Pages 179-188

  Parkkali, T ^a   Kayhty H ^b   Hovi, T ^b   Olander R M ^b   Roivainen, M ^b   Volin, L ^a   Ruutu, T ^a   Lahdenkari, M ^b   Ruutu, P ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPHTHERIA ANTIBODY; DIPHTHERIA TETANUS TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN; IMOVAX POLIO; METHOTREXATE; METHYLPREDNISOLONE; POLIO NOVUM; POLIOMYELITIS VACCINE; TETANUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY BLOOD LEVEL; APLASTIC ANEMIA; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; POLIOMYELITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TETANUS; WHOLE BODY RADIATION;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTIBODY FORMATION; BONE MARROW TRANSPLANTATION; DIPHTHERIA-TETANUS VACCINE; FEMALE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION; MALE; MIDDLE AGED; POLIOVIRUS VACCINE, INACTIVATED; SIBLINGS; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; VACCINES;

EID: 33846624286     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705562     Document Type: Article

References (44)

1. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209-226.
2. Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarström L, Lönnqvist B, Paulin T et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162: 496-500.
3. Engelhard D, Handsher R, Naparstek E, Hardan I, Strauss N, Aker M et al. Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 1991; 8: 295-300.
4. Ljungman P, Duraj V, Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 1991; 7: 89-93.
5. Barra A, Cordonnier C, Preziosi M-P, Intrator L, Hessel L, Fritzell B et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 1992; 166: 1021-1028.
6. Li Volti S, Mauro L, Di Gregorio F, Romeo MA, Lupo L, Pizzarelli G et al. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients. Bone Marrow Transplant 1994; 14: 225-227.
7. Parkkali T, Ruutu T, Stenvik M, Kuronen T, Käyhty H, Hovi T et al. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 1996; 104: 383-388.
8. Parkkali T, Käyhty H, Ruutu T, Volin L, Eskola J, Ruutu P. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplant 1996; 18: 961-967.
9. Parkkali T, Ölander R-M, Ruutu T, Vuontela K, Volin L, Eskola J et al. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 19: 933-938.
10. Parkkali T, Stenvik M, Ruutu T, Hovi T, Volin L, Ruutu P. Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 20: 663-668.
11. Vance E, George S, Guinan EC, Wheeler C, Antin JH, Ambrosino DM et al. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant 1998; 22: 735-741.
12. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: Recapitulation of ontogeny? Bone Marrow Transplant 1993; 12: 387-398.
13. Wimperis JZ, Brenner MK, Prentice HG, Thompson EJ, Hoffbrand AV. B cell development and regulation, after T cell-depleted marrow transplantation. J Immunol 1987; 138: 2445-2450.
14. Molrine DC, Guinan EC, Antin JH, Parsons SK, Weinstein HJ, Wheeler C et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87: 3012-3018.
15. Molrine DC, Antin JH, Guinan EC, Soiffer RJ, MacDonald K, Malley R et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 2003; 101: 831-836.
16. Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53: 720-731.
17. Cordonnier C, Bernaudin J-F, Bierling P, Huet Y, Vernant J-P. Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer 1985; 58: 1047-1054.
18. Aucouturier P, Barra A, Intrator L, Cordonnier C, Schulz D, Duarte F et al. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987; 70: 779-785.
19. Wingard JR. Advances in the management of infectious complications after bone marrow transplantation. Bone Marrow transplant 1990; 6: 371-383.
20. Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, Naparstek E et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 1995; 60: 672-678.
21. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: Global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13: 302-317.
22. Heath PT, McVernon J. The UK Hib vaccine experience. Arch Dis Child 2002; 86: 396-399.
23. Garner D, Weston V. Effectiveness of vaccination for Haemophilus influenzae type b. Lancet 2003; 361: 395-396 (research letter).
24. Ruutu T, Volin L, Parkkali T, Juvonen E, Elonen E. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: A prospective randomized study. Blood 2000; 96: 2391-2398.
25. Thomas ED, Storb R, Clift RA, Feder A, Johnson FL, Neiman PE et al. Bone marrow transplantation (second of two parts). New Engl J Med 1975; 292: 895-902.
26. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
27. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-276.
28. Rapola S. The Finnish vaccination schedule was reformed at the beginning of the year 2005 (In Finnish). Tabu 2005; 1: 4-6.
29. Kristiansen M, Aggerbeck H, Heron I. Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS 1997; 105: 843-853.
30. Mäkelä PH, Käyhty H, Leino T, Auranen K, Peltola H, Ekström N et al. Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. Vaccine 2003; 22: 287-292.
31. Käyhty H, Peltola H, Karanko V, Mäkelä PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983; 147: 1100.
32. Fernandez J, Levine OS, Sanchez J, Balter S, LaClaire L, Feris J et al. Prevention of Haemophilus influenzae type b colonization by vaccination: Correlation with serum anti-capsular IgG concentration. J Infect Dis 2000; 182: 1553-1556.
33. Albrecht P, van Steenis G, van Wezel AL, Salk J. Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis 1984; 6 (S2): S540-S544.
34. Storek J, Dawson MA, Lim LC-L, Burman BE, Stevens-Ayers T, Viganego F et al. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplant 2004; 33: 337-346.
35. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM et al. Age, thymopoiesis, and CD4 + T-lymphocyte regeneration after intensive chemotherapy. New Engl J Med 1995; 332: 143-149.
36. Weinberg K, Annett G, Kashyap A, Lenarsky C, Forman SJ, Parkman R. The effect of thymic function on immunocompetence following bone marrow transplantation. Biol Blood Marrow Transplant 1995; 1: 18-23.
37. Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775-2779.
38. Charbonnier A, Sainty D, Faucher C, Arnoulet C, Chabannon C, Blaise D. Immune reconstitution after blood cell transplantation. Hematol Cell Ther 1997; 39: 261-264.
39. Pavletic ZS, Joshi SS, Pirruccello SJ, Tarantolo SR, Kollath J, Reed EC et al. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant 1998; 21: 33-41.
40. Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97: 3380-3389.
41. Saxon A, Mitsuyasu R, Stevens R, Champlin RE, Kimata H, Gale RP. Designed transfer of specific immune responses with bone marrow transplantation. J Clin Invest 1986; 78: 959-967.
42. Guinan EC, Molrine DC, Antin JH, Lee MC, Weinstein HJ, Sallan SE et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994; 57: 677-684.
43. Engelhard D, Cordonnier C, Shaw PJ, Parkkali T, Guenther C, Martino R et al. Early and late invasive pneumococcal infection following stem cell transplantation: A European Bone Marrow Transplantation survey. Br J Haematol 2002; 117: 444-450.
44. Ljungman P, Aschan J, Gustafsson B, Lewensohn-Fuchs I, Winiarski J, Ringdén O. Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients. Bone Marrow Transplant 2004; 34: 1067-1069.